Safety and efficacy of the Oxford-AstraZeneca vaccine against SARS-CoV-2 after 2nd and 3rd dose in adults: a cross-sectional study
Background: The rapid global spread of the coronavirus SARS-CoV-2 and the lack of established therapeutic choices led to development of several vaccines. Our aim was to investigate the safety and effectiveness of the Oxford-AstraZeneca adenovirus vectored vaccine against SARS-CoV-2 breakthrough infe...
Saved in:
| Main Authors: | Shahrbanoo Sedigh Sarooni, Malihe Mohammadi, Seyed Mohammad Riahi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical University of Gdańsk
2024-12-01
|
| Series: | European Journal of Translational and Clinical Medicine |
| Subjects: | |
| Online Access: | https://ejtcm.gumed.edu.pl/articles/196493.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Legal Problems Using AstraZeneca Vaccine: Hermeneutic Analysis of the Fatwa of the Indonesian Ulema Council
by: Miftahus Sa'diyah, et al.
Published: (2022-01-01) -
Kontroversi Fatwa Astrazeneca: Kontestasi Atau Harmonisasi?
by: Shofiyullah Muzammil, et al.
Published: (2023-03-01) -
New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination
by: Amira Muftah, et al.
Published: (2024-12-01) -
Relationships and Activities. The study is supported by OOO AstraZeneca Pharmaceuticals.
by: E. V. Shlyakhto, et al.
Published: (2023-07-01) -
Middle Cerebral Artery Dissection after AstraZeneca COVID-19 Vaccination
by: Hsin-Wei Wu, et al.
Published: (2025-04-01)